Weaver C. Barksdale & Associates’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$9K Buy
236
+18
+8% +$689 0.01% 301
2017
Q3
$9K Buy
218
+58
+36% +$2.62K 0.01% 294
2017
Q2
$8K Sell
160
-20
-11% -$1.09K 0.01% 310
2017
Q1
$9K Buy
180
+20
+13% +$1.07K 0.01% 297
2016
Q4
$9K Buy
160
+20
+14% +$1.16K 0.01% 298
2016
Q3
$8K Buy
140
+12
+9% +$660 0.01% 306
2016
Q2
$7K Buy
128
+20
+19% +$1.37K 0.01% 312
2016
Q1
$9K Buy
108
+26
+32% +$1.97K 0.01% 293
2015
Q4
$7K Buy
82
+8
+11% +$679 0.01% 330
2015
Q3
$6K Buy
+74
New +$5.59K ﹤0.01% 354

Other funds holding SYNA

Weaver C. Barksdale & Associates's SYNA Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Synaptics (SYNA) stake by 8.3% in Q4 2017, buying an estimated $689 and bringing the position to 236 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #301.

Weaver C. Barksdale & Associates first reported a position in SYNA in Q3 2015 and has held it in 10 quarters since. 240 funds tracked by Wall St. Rank hold SYNA as of Q4 2017.

  • Weaver C. Barksdale & Associates held 236 shares of Synaptics worth $9K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 18 Synaptics shares in Q4 2017, an estimated $689.
  • Synaptics made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #301 holding.
  • Weaver C. Barksdale & Associates first reported a position in Synaptics in Q3 2015 and has held it in 10 quarters since.
  • 240 funds tracked by Wall St. Rank held Synaptics as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.